Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
36.54%
↑ 118% above average
Average (26q)
-203.94%
Historical baseline
Range
High:102.20%
Low:-2627.27%
Volatility
-1338.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 36.54% |
| Q2 2025 | -1281.82% |
| Q1 2025 | 102.20% |
| Q4 2024 | -334.78% |
| Q3 2024 | -675.00% |
| Q2 2024 | 101.33% |
| Q1 2024 | -2627.27% |
| Q4 2023 | -69.23% |
| Q3 2023 | 48.00% |
| Q2 2023 | 84.85% |
| Q1 2023 | -371.43% |
| Q4 2022 | 5.41% |
| Q3 2022 | -54.17% |
| Q2 2022 | 0.00% |
| Q1 2022 | -26.32% |
| Q4 2021 | 48.65% |
| Q3 2021 | -370.14% |
| Q2 2021 | 28.45% |
| Q1 2021 | -81.22% |
| Q4 2020 | 26.42% |
| Q3 2020 | -107.29% |
| Q2 2020 | 2.45% |
| Q1 2020 | 51.37% |
| Q4 2019 | -22.30% |
| Q3 2019 | -21.20% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |